Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INMT | O95050 | 4/20 | 0.95 |
| ▸ | USP2 | O75604 | 2/20 | 0.95 |
| ▸ | ACHE | P22303 | 6/20 | 0.37 |
| ▸ | NOS3 | P29474 | 3/20 | 0.34 |
| ▸ | NOS1 | P29475 | 3/20 | 0.34 |
| ▸ | NOS2 | P35228 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6853620 | 0.98 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL2401189 | 0.98 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL17417853 | 0.98 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL3047 | 0.98 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL16583523 | 0.98 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL10601682 | 0.98 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL2734323 | 0.98 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| Iodide SCHEMBL23365018 | 0.95 | INMT (0.95) | INMTUSP2ACHENOS3NOS1 | |
| Fluoride SCHEMBL14777947 | 0.95 | INMT (0.95) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL2544511 | 0.95 | INMT (0.95) | INMTUSP2ACHENOS3NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6756496-B1 | SUCH AS TRIETHYLAMMONIUM-5'-DIMETHOXYTRITYL-3'-THYMIDINE-HYDROGEN PHOSPHONONDITHIOATE FOR USE AS ANTIVIRAL AND ANTICANCER AGENTS | ISIS PHARMACEUTICALS, INC. | 2004-06-29 | — | — | US | claimed |
| US-5194599-A | Forming linkages with nuclosides and nucleotides; viricides, anticarcinogenic agents | GILEAD SCIENCES, INC. (US) | 1993-03-16 | — | — | US | claimed |
| EP-0360609-A2 | Novel hydrogen phosphonodithioate compositions | GILEAD SCIENCES, INC. (US) | 1990-03-28 | — | — | EP | claimed |
| EP-3894475-B1 | ASSEMBLY COMPONENTS COMPRISING CURABLE COMPOSITIONS CONTAINING ACETOACETYLATED RESINS | EASTMAN CHEM CO (US) | 2024-06-19 | — | — | EP | disclosed |
| EP-3894474-B1 | CURABLE COMPOSITIONS COMPRISING ACETOACETYLATED RESINS, ALDEHYDES AND CERTAIN AMINES | EASTMAN CHEM CO (US) | 2023-09-13 | — | — | EP | disclosed |
| US-20230145775-A1 | IMPACT RESISTANT GARMENT | DESIGN BLUE LIMITED (GB) | 2023-05-11 | — | — | US | disclosed |
| US-11530342-B2 | Curable compositions comprising acetoacetylated resins, aldehydes and certain amines | EASTMAN CHEMICAL COMPANY (US) | 2022-12-20 | — | — | US | disclosed |
| US-11261359-B2 | Flexible substrates comprising curable compositions containing acetoacetylated resins | EASTMAN CHEMICAL COMPANY (US) | 2022-03-01 | — | — | US | disclosed |
| US-20210403646-A1 | ACID-CURABLE COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY | 2021-12-30 | — | — | US | disclosed |
| EP-3894476-A1 | FLEXIBLE SUBSTRATES COMPRISING CURABLE COMPOSITIONS CONTAINING ACETOACETYLATED RESINS | Eastman Chemical Company (US) | 2021-10-20 | — | — | EP | disclosed |
| EP-3894474-A1 | CURABLE COMPOSITIONS COMPRISING ACETOACETYLATED RESINS, ALDEHYDES AND CERTAIN AMINES | Eastman Chemical Company (US) | 2021-10-20 | — | — | EP | disclosed |
| US-5256775-A | Having two or more phosphoramidiate linkages | GILEAD SCIENCES, INC. (US) | 1993-10-26 | — | — | US | disclosed |
| US-5194599-A | Forming linkages with nuclosides and nucleotides; viricides, anticarcinogenic agents | GILEAD SCIENCES, INC. (US) | 1993-03-16 | — | — | US | disclosed |
| EP-0476071-A4 | EXONUCLEASE-RESISTANT OLIGONUCLEOTIDES AND METHODS FOR PREPARING THE SAME | — | 1992-11-04 | — | — | EP | disclosed |
| EP-0476071-A1 | EXONUCLEASE-RESISTANT OLIGONUCLEOTIDES AND METHODS FOR PREPARING THE SAME | GILEAD SCIENCES, INC. (US) | 1992-03-25 | — | — | EP | disclosed |
| WO-1992002535-A1 | AUTOMATED SYSTEM FOR POLYNUCLEOTIDE SYNTHESIS AND PURIFICATION | APPLIED BIOSYSTEMS, INC. (US) | 1992-02-20 | — | — | WO | disclosed |
| US-5047524-A | Solid phase syntheisis o nonsuelladle porous polystyrene support by phosphoramide or hydrogen phosphonate chemistry | APPLIED BIOSYSTEMS, INC. (US) | 1991-09-10 | — | — | US | disclosed |
| WO-1990015065-A1 | EXONUCLEASE-RESISTANT OLIGONUCLEOTIDES AND METHODS FOR PREPARING THE SAME | GILEAD SCIENCES, INC. (US) | 1990-12-13 | — | — | WO | disclosed |
| EP-0375278-A2 | Automated system for polynucleotide synthesis and purification | THE PERKIN-ELMER CORPORATION (US) | 1990-06-27 | — | — | EP | disclosed |
| EP-0360609-A2 | Novel hydrogen phosphonodithioate compositions | GILEAD SCIENCES, INC. (US) | 1990-03-28 | — | — | EP | disclosed |